Delivery Order SPE2DB20D1100-SPE2DB25FA6B7

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,402.91, is a Firm Fixed Price Delivery Order for the supply of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,804.99 firm-fixed-price delivery order is for 4,567,025,743 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,198.05 firm fixed-price delivery order is for the supply of 4,564,942,425 units of the pharmaceutical drug Abiraterone Acetate 500 mg tablets. The contract has a period of performance through June 20, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $94,299.16, has a period of performance through January 8, 2025 and utilizes a firm fixed-price pricing type. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, SPE2DB22D3004|SPE2DB25FNX40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,896.33 Firm Fixed Price Delivery Order contract covers the supply of Abiraterone Acetate 250 mg tablets with an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of abiraterone acetate 250 mg tablets. The contract, valued at $13,348.20, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $103,758.11 firm-fixed-price delivery order is for the supply of 4,566,779,249 units of Abiraterone Acetate 250 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive contracting mechanism...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,968.55 Firm Fixed Price delivery order contract is for the supply of Abiraterone Acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award is a delivery order with a firm fixed price of $1,231.38, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of Abiraterone Acetate 250 mg tablets, with an ultimate completion date of February 21, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award, valued at $4,396.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566832579 - ABIRATERONE ACETATE 500 MG TAB 60S, with a completion date of January 6, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA6B7
    Delivery Order

This federal contract award, valued at $59,784.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 500 mg tablets and is a firm fixed-price delivery order with a completion date of February 14, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The award was not designated with a set-aside requirement, indicating open competition. No subcontractor information was provided in the given details.

Generated 5/22/25, 8:34 PM